Hartford Investment Management CO Abb Vie Inc. Transaction History

Hartford Investment Management CO

  • $2.99 Billion
  • Q3 2024

A detailed history of Hartford Investment Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Hartford Investment Management CO holds 111,167 shares of ABBV stock, worth $19.7 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
111,167
Previous 113,119 1.73%
Holding current value
$19.7 Million
Previous $19.4 Million 13.15%
% of portfolio
0.73%
Previous 0.67%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$163.84 - $199.33 $319,815 - $389,092
-1,952 Reduced 1.73%
111,167 $22 Million
Q2 2024

Aug 01, 2024
SELL
$154.79 - $180.76 $147,979 - $172,806
-956 Reduced 0.84%
113,119 $19.4 Million
Q1 2024

Apr 17, 2024
SELL
$159.82 - $182.1 $775,766 - $883,913
-4,854 Reduced 4.08%
114,075 $20.8 Million
Q4 2023

Jan 23, 2024
SELL
$137.6 - $154.97 $340,835 - $383,860
-2,477 Reduced 2.04%
118,929 $18.4 Million
Q3 2023

Oct 16, 2023
SELL
$133.59 - $154.65 $460,351 - $532,923
-3,446 Reduced 2.76%
121,406 $18.1 Million
Q2 2023

Jul 19, 2023
SELL
$132.51 - $164.9 $3.33 Million - $4.15 Million
-25,163 Reduced 16.77%
124,852 $16.8 Million
Q1 2023

May 09, 2023
SELL
$144.61 - $166.54 $4.58 Million - $5.28 Million
-31,692 Reduced 17.44%
150,015 $23.9 Million
Q4 2022

Jan 20, 2023
SELL
$138.31 - $165.87 $107,881 - $129,378
-780 Reduced 0.43%
181,707 $29.4 Million
Q3 2022

Nov 02, 2022
BUY
$134.21 - $153.93 $228,157 - $261,681
1,700 Added 0.94%
182,487 $24.5 Million
Q2 2022

Jul 22, 2022
BUY
$137.62 - $174.96 $600,986 - $764,050
4,367 Added 2.48%
180,787 $27.7 Million
Q1 2022

Apr 20, 2022
SELL
$131.98 - $163.75 $1.62 Million - $2.01 Million
-12,264 Reduced 6.5%
176,420 $28.6 Million
Q4 2021

Feb 02, 2022
BUY
$107.43 - $135.93 $1.55 Million - $1.96 Million
14,434 Added 8.28%
188,684 $25.5 Million
Q3 2021

Nov 01, 2021
SELL
$106.4 - $120.78 $2.24 Million - $2.54 Million
-21,027 Reduced 10.77%
174,250 $18.8 Million
Q2 2021

Jul 29, 2021
SELL
$105.21 - $117.21 $453,349 - $505,057
-4,309 Reduced 2.16%
195,277 $22 Million
Q1 2021

Apr 21, 2021
SELL
$102.3 - $112.62 $671,599 - $739,350
-6,565 Reduced 3.18%
199,586 $21.6 Million
Q4 2020

Feb 01, 2021
BUY
$80.49 - $108.67 $1.7 Million - $2.29 Million
21,112 Added 11.41%
206,151 $22.1 Million
Q3 2020

Oct 29, 2020
SELL
$85.91 - $100.83 $586,249 - $688,063
-6,824 Reduced 3.56%
185,039 $16.2 Million
Q2 2020

Aug 04, 2020
BUY
$73.37 - $98.18 $1.22 Million - $1.64 Million
16,654 Added 9.51%
191,863 $18.8 Million
Q1 2020

Apr 24, 2020
BUY
$64.5 - $97.79 $147,511 - $223,645
2,287 Added 1.32%
175,209 $13.3 Million
Q4 2019

Jan 29, 2020
SELL
$72.13 - $90.25 $267,602 - $334,827
-3,710 Reduced 2.1%
172,922 $15.3 Million
Q3 2019

Oct 28, 2019
SELL
$62.98 - $75.72 $295,628 - $355,429
-4,694 Reduced 2.59%
176,632 $13.4 Million
Q2 2019

Jul 25, 2019
BUY
$65.7 - $83.98 $108,930 - $139,238
1,658 Added 0.92%
181,326 $13.2 Million
Q1 2019

Apr 29, 2019
BUY
$77.14 - $90.79 $299,303 - $352,265
3,880 Added 2.21%
179,668 $14.5 Million
Q4 2018

Feb 04, 2019
SELL
$77.85 - $96.01 $720,735 - $888,860
-9,258 Reduced 5.0%
175,788 $16.2 Million
Q3 2018

Nov 08, 2018
SELL
$88.91 - $98.84 $255,438 - $283,967
-2,873 Reduced 1.53%
185,046 $17.5 Million
Q2 2018

Jul 19, 2018
SELL
$89.78 - $106.23 $11.7 Million - $13.9 Million
-130,538 Reduced 40.99%
187,919 $17.4 Million
Q1 2018

Apr 24, 2018
SELL
$92.01 - $123.21 $2.6 Million - $3.48 Million
-28,265 Reduced 8.15%
318,457 $30.1 Million
Q4 2017

Feb 12, 2018
SELL
$89.56 - $98.21 $1.64 Million - $1.8 Million
-18,288 Reduced 5.01%
346,722 $33.5 Million
Q3 2017

Nov 13, 2017
BUY
$69.85 - $89.22 $25.5 Million - $32.6 Million
365,010
365,010 $32.4 Million

Others Institutions Holding ABBV

# of Institutions
3,848
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email